MUTATIONS OF THE BCR-ABL- KINASE DOMAIN EXPLAIN THE IMATINIB FAILURE ONLY IN A MINORITY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

被引：0
|
作者：
Jardan, D. [1 ]
Talmaci, R. [1 ]
Coriu, D. [2 ]
Dragomir, M. [2 ]
Ursuleac, I. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Bucharest, Romania
[2] Fundeni Clin Inst, Bucharest, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1333
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [31] Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib
    Sherbenou, D. W.
    Wong, M. J.
    Humayun, A.
    McGreevey, L. S.
    Harrell, P.
    Yang, R.
    Mauro, M.
    Heinrich, M. C.
    Press, R. D.
    Druker, B. J.
    Deininger, M. W.
    LEUKEMIA, 2007, 21 (03) : 489 - 493
  • [32] Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure
    Shih, Lee-Yung
    Kuo, Ming-Chung
    Kuo, Ching-Yuan
    Lin, Tseng-Hsi
    Bai, Li-Yaun
    Chen, Tsai-Yun
    Wang, Ming-Chung
    Lin, Tung-Liang
    Lan, Yii-Jenq
    Chen, Chih-Cheng
    Yang, Youngsen
    Hsiao, Pei-Ching
    Lai, Chang-Liang
    Chang, Chia-Hui
    Lin, Tung-Huei
    LEUKEMIA RESEARCH, 2013, 37 (01) : 43 - 49
  • [33] The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia
    Wang, LH
    Knight, K
    Lucas, C
    Clark, RE
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 235 - 239
  • [34] Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib
    D W Sherbenou
    M J Wong
    A Humayun
    L S McGreevey
    P Harrell
    R Yang
    M Mauro
    M C Heinrich
    R D Press
    B J Druker
    M W Deininger
    Leukemia, 2007, 21 : 489 - 493
  • [35] Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia
    Strhakova, L.
    Bujalkova, M. Gerykova
    Hojsikova, I.
    Lukackova, R.
    Behulova, R.
    Mistrik, M.
    Repiska, V.
    NEOPLASMA, 2011, 58 (06) : 548 - 553
  • [36] Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
    O'Hare, Thomas
    Eide, Christopher A.
    Deininger, Michael W. N.
    BLOOD, 2007, 110 (07) : 2242 - 2249
  • [37] Detection of BCR/ABL kinase domain mutations in chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib treatment.
    Chu, S
    Snyder, DS
    Sawyers, C
    Forman, SJ
    Bhatia, R
    BLOOD, 2003, 102 (11) : 70A - 71A
  • [38] BCR-ABL Kinase Domain Mutations Exist in Few Imatinib Treated Chronic Myeloid Leukemia (CML) Patients Exhibiting Stable Cytogenetic and Hematologic Responses
    Akram, Afia Muhammad
    Akhtar, Tanveer
    Chaudhary, Asma
    Shahzad, Muhammad Mudassar
    Khalid, Ahmad Mukhtar
    Sajid, Nadia
    Sabar, Muhammad Farooq
    Iqbal, Zafar
    BLOOD, 2018, 132
  • [39] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [40] BCR-ABL Mutations in Chronic Myeloid Leukemia
    Ernst, Thomas
    La Rosee, Paul
    Mueller, Martin C.
    Hochhaus, Andreas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
12345